THRYV THERAPEUTICS

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.

#SimilarOrganizations #People #Financial #Website #More

THRYV THERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Therapeutics

Founded:

2019-01-01

Address:

Laval, Quebec, Canada

Country:

Canada

Website Url:

http://www.thryvtrx.com

Total Employee:

1+

Status:

Active

Contact:

+1 514 973 0915

Email Addresses:

[email protected]

Total Funding:

35.38 M USD

Technology used in webpage:

Google Apps For Business Squarespace Hosted

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

Current Advisors List

marc-vidal_image

Marc Vidal Board of Directors @ Thryv Therapeutics
Board_member

jean-françois-pariseau_image

Jean-François Pariseau Board of Directors @ Thryv Therapeutics
Board_member
2021-08-10

daniel-hetu_image

Daniel Hetu Board of Directors @ Thryv Therapeutics
Board_member
2021-08-10

not_available_image

Anthony Rosenzweig Co-Founder & Scientific Advisory Board Member @ Thryv Therapeutics
Board_member

scott-weiner_image

Scott Weiner Board of Directors @ Thryv Therapeutics
Board_member
2021-08-10

Current Employees Featured

not_available_image

Renee Martin
Renee Martin Chief Scientific Officer @ Thryv Therapeutics
Chief Scientific Officer

philip-sager_image

Philip Sager
Philip Sager CMO @ Thryv Therapeutics
CMO

roydon-price_image

Roydon Price
Roydon Price President & COO @ Thryv Therapeutics
President & COO
2014-07-01

paul-f-truex_image

Paul F. Truex
Paul F. Truex CEO,Co-Founder & Chairman @ Thryv Therapeutics
CEO,Co-Founder & Chairman
2019-07-01

debra-odink_image

Debra Odink
Debra Odink Chief Development Officer @ Thryv Therapeutics
Chief Development Officer

Founder

not_available_image

Anthony Rosenzweig

paul-f-truex_image

Paul F. Truex

Investors List

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series A - Thryv Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - Thryv Therapeutics

amzak-health-investors_image

Amzak Health Investors

Amzak Health Investors investment in Series A - Thryv Therapeutics

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Series A - Thryv Therapeutics

amplitude-venture-capital_image

Amplitude Venture Capital

Amplitude Venture Capital investment in Series A - Thryv Therapeutics

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Seed Round - Thryv Therapeutics

Official Site Inspections

http://www.thryvtrx.com Semrush global rank: 8.4 M Semrush visits lastest month: 317

Host Informations
Whois Informations

Loading ...

More informations about "Thryv Therapeutics" on Search Engine